Telegram-
Loading indices

KOSPI · 000520

SamilPharm

Market cap₩179B
PERN/A
PBR1.40×
Foreign ownership3.15%
Avg. analyst target₩10,000

Pension summary

as of Oct 19
streakNone
5D₩0M
20D+₩10M
60D+₩10M
Foreign 20D-₩400M
Inst. 20D+₩10M

Pension daily net buy

-

Cumulative net buying by investor

-
선택 기간의 net buy Total · ₩100M
DateClosePension fundsForeignInstitutionsRetail
10/198,230–-₩40M₩0M+₩40M
10/168,160–+₩40M₩0M-₩40M
10/157,860–+₩130M₩0M-₩130M
10/148,030–+₩50M₩0M-₩50M
10/138,100–+₩90M₩0M-₩90M
10/128,100+₩10M-₩60M+₩10M+₩50M
10/88,300–-₩60M₩0M+₩60M
10/78,440–-₩120M₩0M+₩120M
10/68,700–-₩140M₩0M+₩140M
10/28,640–+₩30M₩0M-₩30M

Discussion

Google-verified members · return since posting
0/300

  1. Loading

세력 매집

last 60 trading days · Oct 19
Foreign 60D−₩500M
Pension funds 60D₩0M
세력 Avg. cost6,886
vs. cost Close+19.5%

Foreign+Pension funds Total 시총의 -0.3%, 60D price 폭 41%·Chg +38.6%. 세력 Avg. cost net buy한 날의 Avg 매수단가로 낸 est.치예요.

세력 매집 구간 All →

Financial score

#499 of KOSPI 500
23.3/100
  • Value6
  • Quality2
  • Growth0
  • Financials2.5
  • Risk12.8
Neutral
All stock scores →

ETF

ETFs holding it in their top 10 · recent changes

10/08 이후 큰 ETF 변화는 없어요

All ETF index changes →

Recent filings

DART
  1. Loading

Broker price targets

Recent 1Y

Recent reports

  1. Earnings 정상화와 구조적 재평가 국면SK Securities · 02/20

Latest report per broker in the past year · Source: Naver Securities Research, Hankyung Consensus · Analyst names masked

Same sector

  1. Samsung Biologics
  2. Celltrion
  3. SAMSUNG EPIS HOLDINGS
  4. Yuhan
  5. SK Biopharm
  6. HanmiPharm

SamilPharm summary

SamilPharm (000520). Pension funds last 20 trading days +₩10M. Market cap ₩179B, PER N/A, PBR 1.40×. Avg. analyst target ₩10,000. Pension flows are based on Korea Exchange investor statistics, for reference only.